# NeoKor commissions heart valve bioprostheses plant in Kemerovo

NeoKor has commissioned a production facility in Kemerovo, Russia, for heart valve bioprostheses and other cardiovascular medical devices. Total investment was 346 million roubles, with capacity to produce 4,500 units per year, up from 2,000.

- Type: New facility
- Announced: 2026-03-25
- Where: Kemerovo, Kuzbass, Russia
- Value: $3.80M (346.0M RUB)
- Starts operating: 25 Mar 2026
- Status: completed
- Capacity: 4,500 units per year
- Products: heart valve bioprostheses, annuloplasty rings, cardiovascular patches, vascular bioprostheses
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [NeoKor](https://endata.com/companies/91024.md)

## Sources

- [gxpnews.net](https://gxpnews.net/en/2026/03/a-plant-for-manufacturing-heart-valve-bioprostheses-has-been-launched-in-kuzbass/), 2026-03-25: "NeoKor has commissioned a production facility in Kemerovo specialising in heart valve bioprostheses and other medical devices for cardiovascular surgery."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.